OPTIMIZERX CORP (OPRX) Fundamental Analysis & Valuation

NASDAQ:OPRX • US68401U2042

6.74 USD
-0.79 (-10.49%)
At close: Mar 6, 2026
6.67 USD
-0.07 (-1.04%)
After Hours: 3/6/2026, 9:42:32 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This OPRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, OPRX scores 5 out of 10 in our fundamental rating. OPRX was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of OPRX get a neutral evaluation. Nothing too spectacular is happening here. OPRX scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. OPRX Profitability Analysis

1.1 Basic Checks

  • OPRX had positive earnings in the past year.
  • In the past year OPRX had a positive cash flow from operations.
  • OPRX had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: OPRX reported negative operating cash flow in multiple years.
OPRX Yearly Net Income VS EBIT VS OCF VS FCFOPRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

  • With a decent Return On Assets value of 0.02%, OPRX is doing good in the industry, outperforming 77.14% of the companies in the same industry.
  • The Return On Equity of OPRX (0.03%) is better than 77.14% of its industry peers.
  • OPRX has a Return On Invested Capital of 3.51%. This is in the better half of the industry: OPRX outperforms 71.43% of its industry peers.
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROIC 3.51%
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
OPRX Yearly ROA, ROE, ROICOPRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • OPRX's Profit Margin of 0.03% is fine compared to the rest of the industry. OPRX outperforms 77.14% of its industry peers.
  • OPRX has a better Operating Margin (6.17%) than 74.29% of its industry peers.
  • With a Gross Margin value of 65.31%, OPRX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • OPRX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.17%
PM (TTM) 0.03%
GM 65.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
OPRX Yearly Profit, Operating, Gross MarginsOPRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. OPRX Health Analysis

2.1 Basic Checks

  • OPRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for OPRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OPRX Yearly Shares OutstandingOPRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
OPRX Yearly Total Debt VS Total AssetsOPRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • OPRX has an Altman-Z score of 2.10. This is not the best score and indicates that OPRX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • OPRX's Altman-Z score of 2.10 is fine compared to the rest of the industry. OPRX outperforms 68.57% of its industry peers.
  • The Debt to FCF ratio of OPRX is 2.43, which is a good value as it means it would take OPRX, 2.43 years of fcf income to pay off all of its debts.
  • OPRX's Debt to FCF ratio of 2.43 is fine compared to the rest of the industry. OPRX outperforms 68.57% of its industry peers.
  • OPRX has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.20, OPRX is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • Even though the debt/equity ratio score it not favorable for OPRX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.43
Altman-Z 2.1
ROIC/WACC0.3
WACC11.54%
OPRX Yearly LT Debt VS Equity VS FCFOPRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 3.05 indicates that OPRX has no problem at all paying its short term obligations.
  • OPRX has a Current ratio of 3.05. This is in the better half of the industry: OPRX outperforms 68.57% of its industry peers.
  • OPRX has a Quick Ratio of 3.05. This indicates that OPRX is financially healthy and has no problem in meeting its short term obligations.
  • OPRX has a better Quick ratio (3.05) than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 3.05
Quick Ratio 3.05
OPRX Yearly Current Assets VS Current LiabilitesOPRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. OPRX Growth Analysis

3.1 Past

  • OPRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 212.12%, which is quite impressive.
  • The Earnings Per Share has been growing by 40.22% on average over the past years. This is a very strong growth
EPS 1Y (TTM)212.12%
EPS 3Y43.3%
EPS 5Y40.22%
EPS Q2Q%70%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.24%

3.2 Future

  • Based on estimates for the next years, OPRX will show a small growth in Earnings Per Share. The EPS will grow by 1.97% on average per year.
  • Based on estimates for the next years, OPRX will show a quite strong growth in Revenue. The Revenue will grow by 10.87% on average per year.
EPS Next Y-13.02%
EPS Next 2Y1.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.33%
Revenue Next 2Y10.87%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
OPRX Yearly Revenue VS EstimatesOPRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
OPRX Yearly EPS VS EstimatesOPRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

7

4. OPRX Valuation Analysis

4.1 Price/Earnings Ratio

  • OPRX is valuated cheaply with a Price/Earnings ratio of 6.54.
  • Based on the Price/Earnings ratio, OPRX is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of OPRX to the average of the S&P500 Index (26.29), we can say OPRX is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 7.52, the valuation of OPRX can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of OPRX indicates a rather cheap valuation: OPRX is cheaper than 91.43% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.57. OPRX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.54
Fwd PE 7.52
OPRX Price Earnings VS Forward Price EarningsOPRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • OPRX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. OPRX is cheaper than 71.43% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, OPRX is valued cheaper than 88.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.86
EV/EBITDA 13.43
OPRX Per share dataOPRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y1.97%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OPRX Dividend Analysis

5.1 Amount

  • No dividends for OPRX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OPRX Fundamentals: All Metrics, Ratios and Statistics

OPTIMIZERX CORP

NASDAQ:OPRX (3/6/2026, 9:42:32 PM)

After market: 6.67 -0.07 (-1.04%)

6.74

-0.79 (-10.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-05
Earnings (Next)05-11
Inst Owners74.75%
Inst Owner Change-0.18%
Ins Owners12.93%
Ins Owner Change0.25%
Market Cap125.63M
Revenue(TTM)N/A
Net Income(TTM)32.00K
Analysts83.08
Price Target24.82 (268.25%)
Short Float %10.73%
Short Ratio4.95
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)807.75%
Min EPS beat(2)342.72%
Max EPS beat(2)1272.78%
EPS beat(4)4
Avg EPS beat(4)447.32%
Min EPS beat(4)8.43%
Max EPS beat(4)1272.78%
EPS beat(8)7
Avg EPS beat(8)250.62%
EPS beat(12)10
Avg EPS beat(12)191.95%
EPS beat(16)13
Avg EPS beat(16)147.27%
Revenue beat(2)2
Avg Revenue beat(2)17.89%
Min Revenue beat(2)7.23%
Max Revenue beat(2)28.56%
Revenue beat(4)4
Avg Revenue beat(4)13.8%
Min Revenue beat(4)4.37%
Max Revenue beat(4)28.56%
Revenue beat(8)6
Avg Revenue beat(8)4.84%
Revenue beat(12)8
Avg Revenue beat(12)2.3%
Revenue beat(16)8
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.85%
EPS NY rev (1m)0%
EPS NY rev (3m)12.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.56%
Valuation
Industry RankSector Rank
PE 6.54
Fwd PE 7.52
P/S 1.15
P/FCF 10.86
P/OCF 10.62
P/B 1.03
P/tB 14.03
EV/EBITDA 13.43
EPS(TTM)1.03
EY15.28%
EPS(NY)0.9
Fwd EY13.29%
FCF(TTM)0.62
FCFY9.21%
OCF(TTM)0.63
OCFY9.41%
SpS5.87
BVpS6.56
TBVpS0.48
PEG (NY)N/A
PEG (5Y)0.16
Graham Number12.33
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROCE 4.45%
ROIC 3.51%
ROICexc 4.03%
ROICexgc 28.04%
OM 6.17%
PM (TTM) 0.03%
GM 65.31%
FCFM 10.56%
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.43
Debt/EBITDA 2.24
Cap/Depr 5.95%
Cap/Sales 0.24%
Interest Coverage 1.25
Cash Conversion 106.61%
Profit Quality 36153.1%
Current Ratio 3.05
Quick Ratio 3.05
Altman-Z 2.1
F-Score7
WACC11.54%
ROIC/WACC0.3
Cap/Depr(3y)19.52%
Cap/Depr(5y)17.6%
Cap/Sales(3y)0.7%
Cap/Sales(5y)0.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)212.12%
EPS 3Y43.3%
EPS 5Y40.22%
EPS Q2Q%70%
EPS Next Y-13.02%
EPS Next 2Y1.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.24%
Revenue Next Year11.33%
Revenue Next 2Y10.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y156.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.66%
EBIT Next 3Y53.84%
EBIT Next 5YN/A
FCF growth 1Y115790%
FCF growth 3Y154.28%
FCF growth 5YN/A
OCF growth 1Y549.84%
OCF growth 3Y88.49%
OCF growth 5YN/A

OPTIMIZERX CORP / OPRX FAQ

What is the ChartMill fundamental rating of OPTIMIZERX CORP (OPRX) stock?

ChartMill assigns a fundamental rating of 5 / 10 to OPRX.


Can you provide the valuation status for OPTIMIZERX CORP?

ChartMill assigns a valuation rating of 7 / 10 to OPTIMIZERX CORP (OPRX). This can be considered as Undervalued.


How profitable is OPTIMIZERX CORP (OPRX) stock?

OPTIMIZERX CORP (OPRX) has a profitability rating of 4 / 10.


How financially healthy is OPTIMIZERX CORP?

The financial health rating of OPTIMIZERX CORP (OPRX) is 6 / 10.


What is the earnings growth outlook for OPTIMIZERX CORP?

The Earnings per Share (EPS) of OPTIMIZERX CORP (OPRX) is expected to decline by -13.02% in the next year.